Publications by authors named "Scott D Berkowitz"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,056

Total Likes

60

Extended Reach

64,217

Social Features

27
R
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Robert G Hart, Mukul Sharma, Hardi Mundl, Scott E Kasner, Shrikant I Bangdiwala, Scott D Berkowitz, Balakumar Swaminathan, Pablo Lavados, Yongjun Wang, Yilong Wang

June 2018

Videos about Article: user user user

3 1 33 23 4 14

View All Article and Social Media Activity
L
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence.
Mario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, Connie N Hess, Luca Bardi, Scott D Berkowitz

Clin Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription of aspirin plus low-dose rivaroxaban in patients with peripheral artery disease after lower-extremity revascularization.
Mario Enrico Canonico, Connie N Hess, Sivan Naveh, R Kevin Rogers, Mark R Nehler, Scott D Berkowitz

Vasc Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial.
R Kevin Rogers, Eike Sebastian Debus, Manesh R Patel, Sonia S Anand, Eva Muehlhofer, Scott D Berkowitz

JACC Cardiovasc Interv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization.
Mario Enrico Canonico, Cecilia C Low Wang, Judith Hsia, E Sebastian Debus, Mark R Nehler, Scott D Berkowitz

J Am Coll Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, Günter Breithardt, Jonathan L Halperin, Scott D Berkowitz

J Am Heart Assoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
Justin T Morrison, Mario Enrico Canonico, Sonia S Anand, Manesh R Patel, Eike Sebastian Debus, Scott D Berkowitz

Circulation· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD.
R Kevin Rogers, Joerg Herold, Nicholas Govsyeyev, Roberto Iezzi, Justin Morrison, Scott D Berkowitz

Vasc Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz

J Am Heart Assoc· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.
Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, Manesh R Patel, Sonia S Anand, Scott D Berkowitz

Circulation· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
Jennifer Rymer, Sonia S Anand, E Sebastian Debus, Lloyd P Haskell, Connie N Hess, Scott D Berkowitz

Circulation· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Nicholas Govsyeyev, Mark Nehler, Michael S Conte, Sebastian Debus, Jayer Chung, Scott D Berkowitz

J Vasc Surg· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.
Mario Enrico Canonico, Raffaele Piccolo, Marisa Avvedimento, Attilio Leone, Salvatore Esposito, Scott D Berkowitz

J Cardiovasc Dev Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
Marc P Bonaca, Michael Szarek, E Sebastian Debus, Mark R Nehler, Manesh R Patel, Scott D Berkowitz

Clin Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.
Mukul Sharma, Eric E Smith, Lesly A Pearce, Kanjana S Perera, Scott E Kasner, Scott D Berkowitz

Int J Stroke· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD.
Shea E Hogan, Mark R Nehler, Sonia Anand, Manesh R Patel, Sebastian Debus, Scott D Berkowitz

Vasc Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Connie N Hess, Iris Baumgartner, Sonia S Anand, Mark R Nehler, Manesh R Patel, Scott D Berkowitz

J Am Heart Assoc· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Connie N Hess, Michael Szarek, Sonia S Anand, Rupert M Bauersachs, Manesh R Patel, Scott D Berkowitz

JAMA Netw Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
Sonia S Anand, Will Hiatt, Leanne Dyal, Rupert Bauersachs, Scott D Berkowitz

Eur J Prev Cardiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
Scott D Berkowitz, Rupert M Bauersachs, Michael Szarek, Mark R Nehler, E Sebastian Debus

J Thromb Haemost· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial.
Mukul Sharma, Eric E Smith, Lesly A Pearce, Ashkan Shoamanesh, Kanjana S Perera, Scott D Berkowitz

Stroke· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Connie N Hess, E Sebastian Debus, Mark R Nehler, Sonia S Anand, Manesh R Patel, Scott D Berkowitz

Circulation· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Connie N Hess, Manesh R Patel, Rupert M Bauersachs, Sonia S Anand, E Sebastian Debus, Scott D Berkowitz

J Am Coll Cardiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
Mori J Krantz, Sebastian E Debus, Judith Hsia, Manesh R Patel, Sonia S Anand, Scott D Berkowitz

Eur Heart J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial.
Anthony P Carnicelli, Anne S Hellkamp, Kenneth W Mahaffey, Daniel E Singer, Günter Breithardt, Scott D Berkowitz

J Am Heart Assoc· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.
Judith Hsia, Michael Szarek, Sonia Anand, Manesh R Patel, Sebastian Debus, Scott D Berkowitz

J Am Coll Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis